RISEDRONATE ACCORD 35 mg, film-coated tablet 12 tablets
Active ingredients: Risedronic acid, Risedronate sodium hemi-pentahydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet12 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RISEDRONATE ACCORD 35 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 3 plaquette(s) PVC PVDC aluminium de 4 comprimé(s)
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 May 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66887599CIP74961937CIP133400949619375Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RISÉDRONATE MONOSODIQUEcomprimé | 35 mg · un comprimé | SA |
| ACIDE RISÉDRONIQUEcomprimé | 32,5 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.